Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia–related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity
- Resource Type
- Article
- Source
- In
Prostate International December 2020 8(4):152-157 - Subject
- Language
- ISSN
- 2287-8882